ATE vs. RVX, AEZS, APS, HBP, MBX, BCT, WLLW, and VPH
Should you be buying Antibe Therapeutics stock or one of its competitors? The main competitors of Antibe Therapeutics include Resverlogix (RVX), Aeterna Zentaris (AEZS), Aptose Biosciences (APS), Helix BioPharma (HBP), Microbix Biosystems (MBX), BriaCell Therapeutics (BCT), Willow Biosciences (WLLW), and Valeo Pharma (VPH). These companies are all part of the "medical" sector.
Antibe Therapeutics (TSE:ATE) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership, earnings and community ranking.
Resverlogix has lower revenue, but higher earnings than Antibe Therapeutics. Resverlogix is trading at a lower price-to-earnings ratio than Antibe Therapeutics, indicating that it is currently the more affordable of the two stocks.
In the previous week, Antibe Therapeutics' average media sentiment score of 0.00 equaled Resverlogix'saverage media sentiment score.
Resverlogix's return on equity of 0.00% beat Antibe Therapeutics' return on equity.
Resverlogix received 121 more outperform votes than Antibe Therapeutics when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 74.41% of users gave Antibe Therapeutics an outperform vote.
Antibe Therapeutics has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500. Comparatively, Resverlogix has a beta of 0.78, suggesting that its stock price is 22% less volatile than the S&P 500.
Summary
Resverlogix beats Antibe Therapeutics on 6 of the 9 factors compared between the two stocks.
Get Antibe Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Antibe Therapeutics Competitors List
Related Companies and Tools
